Summit Therapeutics (SMMT) Revenue (2019 - 2022)
Summit Therapeutics (SMMT) reported Revenue of $220000.0 for Q3 2022, down 83.19% on a YoY basis from $1.3 million in Q3 2021, and down 6.38% quarter-over-quarter from $235000.0 in Q2 2022.
Summit Therapeutics (SMMT) Revenue (2019 - 2022) Analysis & Trends
Summit Therapeutics has reported Revenue for 4 years, with the latest figure at $220000.0 in Q3 2022.
- For the quarter ending Q3 2022, Revenue fell 83.19% year-over-year to $220000.0; the trailing twelve-month figure through Jun 2023 stood at $220000.0 (down 89.24% YoY), and the FY2022 full-year result was $705000.0, down 61.03% from the prior year.
- Revenue for Q3 2022 stood at $220000.0, down from $235000.0 in the prior quarter.
- The five-year high for Revenue was $1.3 million in Q3 2021, with the low at -$52000.0 in Q4 2019.
- Historically, Revenue has averaged $266923.1 across 4 years, with a median of $192000.0 in 2021.
- Annual changes were most pronounced in 2021 — Revenue soared 623.2% — and 2022, when it plunged 83.19%.
- Summit Therapeutics' Revenue stood at -$52000.0 in 2019, then soared by 455.77% to $185000.0 in 2020, then soared by 35.68% to $251000.0 in 2021, then retreated by 12.35% to $220000.0 in 2022.
- The last three Revenue figures came in at $220000.0 (Q3 2022), $235000.0 (Q2 2022), and $250000.0 (Q1 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 5.21 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 306.30 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 2.99 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Summit Therapeutics | 10.09 Bn | 9.99 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 220,000.00 |
| Jun 30, 2022 | 235,000.00 |
| Mar 31, 2022 | 250,000.00 |
| Dec 31, 2021 | 251,000.00 |
| Sep 30, 2021 | 1.31 Mn |
| Jun 30, 2021 | 57,000.00 |
| Mar 31, 2021 | 192,000.00 |
| Dec 31, 2020 | 185,000.00 |
| Sep 30, 2020 | 181,000.00 |
| Jun 30, 2020 | 170,000.00 |
| Mar 31, 2020 | 324,000.00 |
| Dec 31, 2019 | -52,000.00 |
| Sep 30, 2019 | 148,000.00 |